Received Jun 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | J4K4X | RA |
| IPV | POLIO VIRUS, INACT. (IPOL) | SANOFI PASTEUR | 7+ | W1C741M | IM / RA |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 2 | Y009430 | IM / LA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 5YB5G | IM / LA |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | Y011019 | IM / LA |
Said experienced an adverse reaction following administration of five vaccines at his last well-child visit. Symptoms included immediate onset (within 2 hours) of generalized pruritus lasting 1-2 days, tingling sensation persisting for 4-5 days, and development of white spots on his face. Physical examination revealed a 1x2 cm hypopigmented region collateral to the right nostril. The reaction's specific cause is unclear due to multiple vaccines being administered simultaneously.
No acute illness at time of vaccine or one month prior.
Dyslipidemia, newly diagnosed.
None
None
None, acute phase had passed when parents/patient reported reaction.